The current institutional shareholding score of Perspective Therapeutics Inc is 5.00, ranking 133 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 54.19%, representing a quarter-over-quarter decrease of 34.77%. The largest institutional shareholder is Paul Tudor Jones, holding a total of 34.03K shares, representing 0.03% of shares outstanding, with 0.67% increase in holdings.